Scion Advisors

Scion Life Sciences is a New York City-based venture capital firm dedicated to founding and building biotechnology companies that discover, develop, and commercialize clinically transformational or curative new medicines. It recently closed an oversubscribed $310 million inaugural fund. The team actively incubates startups internally and provides long-term operational support with the goal of creating sustainable biopharmaceutical enterprises capable of advancing therapies from pre-seed through IPO/commercialization. No clinical results are reported at the fund level; outcomes will depend on individual portfolio companies yet to be publicly detailed.